Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor.

Gao M, Wang M, Green MA, Hutchins GD, Zheng QH.

Bioorg Med Chem Lett. 2015 Mar 14. pii: S0960-894X(15)00217-6. doi: 10.1016/j.bmcl.2015.03.021. [Epub ahead of print]

PMID:
25819093
2.

In vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal Bound Water in Skeletally Mature Beagle Dogs.

Allen MR, Territo PR, Lin C, Persohn S, Jiang L, Riley AA, McCarthy BP, Newman CL, Burr DB, Hutchins GD.

J Bone Miner Res. 2015 Jan 31. doi: 10.1002/jbmr.2470. [Epub ahead of print]

PMID:
25644867
3.

Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers.

Deters KD, Risacher SL, Farlow MR, Unverzagt FW, Kareken DA, Hutchins GD, Yoder KK, Murrell JR, Spina S, Epperson F, Gao S, Saykin AJ, Ghetti B.

Am J Neurodegener Dis. 2014 Dec 5;3(3):103-14. eCollection 2014.

4.

Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.

Fletcher JW, Logan TF, Eitel JA, Mathias CJ, Ng Y, Lacy JL, Hutchins GD, Green MA.

J Nucl Med. 2015 Jan;56(1):56-62. doi: 10.2967/jnumed.114.148106. Epub 2014 Dec 18.

PMID:
25525184
5.

Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake.

Yoder KK, Territo PR, Hutchins GD, Hannestad J, Morris ED, Gallezot JD, Normandin MD, Cosgrove KP.

Nucl Med Biol. 2015 Mar;42(3):305-8. doi: 10.1016/j.nucmedbio.2014.11.003. Epub 2014 Nov 15.

PMID:
25487553
6.

The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.

Weber DJ, Gracon AS, Ripsch MS, Fisher AJ, Cheon BM, Pandya PH, Vittal R, Capitano ML, Kim Y, Allette YM, Riley AA, McCarthy BP, Territo PR, Hutchins GD, Broxmeyer HE, Sandusky GE, White FA, Wilkes DS.

Sci Transl Med. 2014 Sep 3;6(252):252ra124. doi: 10.1126/scitranslmed.3009443.

PMID:
25186179
7.

Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.

Lea WB, Tapp KN, Tann M, Hutchins GD, Fletcher JW, Johnson MS.

J Vasc Interv Radiol. 2014 Oct;25(10):1595-603. doi: 10.1016/j.jvir.2014.06.028. Epub 2014 Aug 23.

PMID:
25156647
8.

The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.

Tapp KN, Lea WB, Johnson MS, Tann M, Fletcher JW, Hutchins GD.

J Nucl Med. 2014 Sep;55(9):1452-8. doi: 10.2967/jnumed.113.133629. Epub 2014 Jun 30.

PMID:
24982437
9.

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Moberly SP, Mather KJ, Berwick ZC, Owen MK, Goodwill AG, Casalini ED, Hutchins GD, Green MA, Ng Y, Considine RV, Perry KM, Chisholm RL, Tune JD.

Basic Res Cardiol. 2013 Jul;108(4):365. doi: 10.1007/s00395-013-0365-x. Epub 2013 Jun 14.

10.

Equivalence of arterial and venous blood for [11C]CO2-metabolite analysis following intravenous administration of 1-[11C]acetate and 1-[11C]palmitate.

Ng Y, Moberly SP, Mather KJ, Brown-Proctor C, Hutchins GD, Green MA.

Nucl Med Biol. 2013 Apr;40(3):361-5. doi: 10.1016/j.nucmedbio.2012.11.011. Epub 2013 Jan 8.

PMID:
23306135
11.

PARP1 gene variation and microglial activity on [11C]PBR28 PET in older adults at risk for Alzheimer's disease.

Kim S, Nho K, Risacher SL, Inlow M, Swaminathan S, Yoder KK, Shen L, West JD, McDonald BC, Tallman EF, Hutchins GD, Fletcher JW, Farlow MR, Ghetti B, Saykin AJ.

Multimodal Brain Image Anal (2013). 2013;8159:150-158.

12.

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW.

Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23.

PMID:
23099009
13.

A new facile synthetic route to [11C]GSK189254, a selective PET radioligand for imaging of CNS histamine H3 receptor.

Wang M, Gao M, Steele BL, Glick-Wilson BE, Brown-Proctor C, Shekhar A, Hutchins GD, Zheng QH.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4713-8. doi: 10.1016/j.bmcl.2012.05.076. Epub 2012 May 26.

PMID:
22687746
14.

Striatal dopamine transporter availability in unmedicated bipolar disorder.

Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH, Hutchins GD, Normandin MD, Yoder KK.

Bipolar Disord. 2011 Jun;13(4):406-13. doi: 10.1111/j.1399-5618.2011.00936.x.

PMID:
21843280
15.

Positron emission tomography (PET) assessment of renal perfusion.

Green MA, Hutchins GD.

Semin Nephrol. 2011 May;31(3):291-9. doi: 10.1016/j.semnephrol.2011.05.008.

PMID:
21784278
16.

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Murphy MP, Lawson JH, Rapp BM, Dalsing MC, Klein J, Wilson MG, Hutchins GD, March KL.

J Vasc Surg. 2011 Jun;53(6):1565-74.e1. doi: 10.1016/j.jvs.2011.01.074. Epub 2011 Apr 22.

17.

Synthesis of carbon-11-labeled bivalent β-carbolines as new PET agents for imaging of cholinesterase in Alzheimer's disease.

Wang M, Zheng DX, Gao M, Hutchins GD, Zheng QH.

Appl Radiat Isot. 2011 Apr;69(4):678-85. doi: 10.1016/j.apradiso.2011.01.004. Epub 2011 Jan 8.

PMID:
21256758
18.

Assessment of i.p. injection of [18F]fallypride for behavioral neuroimaging in rats.

Yoder KK, Mock BH, Zheng QH, McCarthy BP, Riley AA, Hutchins GD.

J Neurosci Methods. 2011 Mar 15;196(1):70-5. doi: 10.1016/j.jneumeth.2010.12.027. Epub 2011 Jan 8.

PMID:
21219928
19.

The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

Wang M, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):245-9. doi: 10.1016/j.bmcl.2010.11.026. Epub 2010 Nov 11.

PMID:
21115250
20.

The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent.

Wang M, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

Nucl Med Biol. 2010 Oct;37(7):763-75. doi: 10.1016/j.nucmedbio.2010.04.186.

PMID:
20870151
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk